you are here: HomeNewsBioconVideos
biocon
Jump to
782 Results Found
  • Exclusive | Goldman Sachs Private Equity in talks to buy minority stake in IPO-bound Biocon Biologics Oct 01, 2020 09:29 PM IST

    Exclusive | Goldman Sachs Private Equity in talks to buy minority stake in IPO-bound Biocon Biologics

    If the deal — which may value the firm in excess of $3.5 billion — fructifies, it would mark the third successive investment in 2020 for Kiran Mazumdar Shaw-led Biocon Biologics

  • Cadila: a formidable play in Covid times and beyond Sep 25, 2020 09:39 AM IST

    Cadila: a formidable play in Covid times and beyond

    Cadila is not only a credible Indian pharma striving for a Covid solution, but on a longer time scale is an interesting watch in the large-cap space witnessing a significant transformation in product portfolio.

  • Pharma: Trump’s executive orders may possibly provide better market access opportunities Jul 27, 2020 11:43 AM IST

    Pharma: Trump’s executive orders may possibly provide better market access opportunities

    Indian drugmakers such as Cipla, Cadila, Lupin, Dr Reddy’s, Sun Pharma and a few small-sized pharma companies such as Laurus Labs may benefit from a likely revamp of US medicare

  • Market Headstart: Nifty is seen opening higher; HDFC Life, Avanti Feeds top buys Dec 13, 2019 08:11 AM IST

    Market Headstart: Nifty is seen opening higher; HDFC Life, Avanti Feeds top buys

    Trends on SGX Nifty indicate a positive opening for the broader index in India, with a 30 points gain. Nifty futures were trading around 12,050 levels on the Singaporean Exchange

  • Market Headstart: Nifty seen opening flat; BEML, Kotak Mahindra Bank top buys Dec 03, 2019 08:13 AM IST

    Market Headstart: Nifty seen opening flat; BEML, Kotak Mahindra Bank top buys

    Trends on SGX Nifty indicate a negative opening for the broader index in India with a 17.5 points loss. Nifty futures were trading around 12,074-levels on the Singaporean Exchange

  • Market Headstart: Nifty50 seen opening higher; HCL Tech, Hero MotoCorp eyed Oct 24, 2019 08:14 AM IST

    Market Headstart: Nifty50 seen opening higher; HCL Tech, Hero MotoCorp eyed

    Trends on SGX Nifty indicate a positive opening for the broader index in India, with a 27.5 points gain or 0.24 percent. Nifty futures were trading around 11,666-level on the Singaporean Exchange.

  • Market Headstart: Nifty likely to open flat; 3 stocks which could give 8-10% return Jul 16, 2019 08:48 AM IST

    Market Headstart: Nifty likely to open flat; 3 stocks which could give 8-10% return

    Trends on SGX Nifty indicate a flat to negative opening for the broader index in India, a fall of 7.5 points or 0.06 percent. Nifty futures were trading around 11,539-level on the Singaporean Exchange.

  • Biocon chief Kiran Mazumdar-Shaw wants Congress to commit to growth of digital economy Jan 21, 2019 08:25 AM IST

    Biocon chief Kiran Mazumdar-Shaw wants Congress to commit to growth of digital economy

    A billionaire entrepreneur and founder of the country's leading biotechnology firm Biocon, Mazumdar gave this suggestion to the Congress during the party's 'manifesto consultation meeting on IT and BT Economy', chaired by P Chidambaram here.

  • Expect steady growth in biosimilars segment going forward, says Kiran Mazumdar Shaw of Biocon Oct 26, 2018 09:36 PM IST

    Expect steady growth in biosimilars segment going forward, says Kiran Mazumdar Shaw of Biocon

    “Overall, we have a nice basket of biosimilars for both the US and European market, which will set us up for a steady growth in that segment going forward,” said Shaw.

  • Plan to enter EU market with Insulin Glargine in second half of the year: Biocon Mar 28, 2018 03:21 PM IST

    Plan to enter EU market with Insulin Glargine in second half of the year: Biocon

    We are now ready to enter the European market with our Insulin Glargine as a biosimilar, in the second half of this year, said Kiran Mazumdar Shaw, CMD, Biocon.

  • Syngene's multi-year agreement with GSK to focus on research: Jonathan Hunt Mar 26, 2018 01:56 PM IST

    Syngene's multi-year agreement with GSK to focus on research: Jonathan Hunt

    The agreement with GSK is more to support their research focus and not a specific drug pipeline, said Jonathan Hunt, CEO, Syngene International

  • Top buy & sell ideas by Ashwani Gujral, Mitessh Thakkar & Prakash Gaba for March 12 Mar 12, 2018 08:30 AM IST

    Top buy & sell ideas by Ashwani Gujral, Mitessh Thakkar & Prakash Gaba for March 12

    Ashwani Gujral of ashwanigujral.com recommends buying Tech Mahindra with a stop loss of Rs 614 and target of Rs 635 and has a buy also on Tata Consultancy Services with a stop loss of Rs 3000, target of Rs 3150.

  • Top buy & sell ideas by Ashwani Gujral, Mitessh Thakkar & Prakash Gaba for March 9 Mar 09, 2018 08:28 AM IST

    Top buy & sell ideas by Ashwani Gujral, Mitessh Thakkar & Prakash Gaba for March 9

    Ashwani Gujral of ashwanigujral.com recommends buying Titan Company with a stop loss of Rs 810, target of Rs 840, Reliance Industries with a stop loss of Rs 900, target of Rs 925 and a buy also on Jubilant Foodworks with a stop loss of Rs 1990, target of Rs 2050.

  • Buy Biocon, LIC Housing, Voltas; sell TVS Motor, Century Textiles, Interglobe Aviation: Ashwani Gujral Mar 06, 2018 02:24 PM IST

    Buy Biocon, LIC Housing, Voltas; sell TVS Motor, Century Textiles, Interglobe Aviation: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one can buy Biocon, LIC Housing and Voltas and can sell TVS Motor, Century Textiles and Interglobe Aviation.

  • Buy Indiabulls Housing Finance, Motilal Oswal, Biocon, Titan, Motherson Sumi: Ashwani Gujral Feb 22, 2018 01:34 PM IST

    Buy Indiabulls Housing Finance, Motilal Oswal, Biocon, Titan, Motherson Sumi: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Indiabulls Housing Finance, Motilal Oswal, Biocon, Titan Company an Motherson Sumi Systems.

  • Buy Biocon, TCS; sell Hindalco Industries: Rajat Bose Feb 22, 2018 11:00 AM IST

    Buy Biocon, TCS; sell Hindalco Industries: Rajat Bose

    Rajat Bose of rajatkbose.com is of the view that one can buy Biocon and TCS and can sell Hindalco Industries.

  • Sell Raymond, Titan Company; buy Biocon: Ashwani Gujral Feb 16, 2018 01:36 PM IST

    Sell Raymond, Titan Company; buy Biocon: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one can sell Raymond and Titan Company and can buy Biocon.

  • Buy Biocon, Ajanta Pharma, Ashok Leyland: Rajat Bose Feb 08, 2018 02:28 PM IST

    Buy Biocon, Ajanta Pharma, Ashok Leyland: Rajat Bose

    Rajat Bose of rajatkbose.com recommends buying Biocon, Ajanta Pharma and Ashok Leyland.

  • Sell ONGC, SRF, Marico;  buy Biocon, DLF: Sudarshan Sukhani Feb 06, 2018 10:23 AM IST

    Sell ONGC, SRF, Marico; buy Biocon, DLF: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com suggests selling ONGC, SRF and Marico.

  • Buy Bajaj Auto, Biocon; sell Canara Bank, Chennai Petro: Sudarshan Sukhani Feb 02, 2018 11:26 AM IST

    Buy Bajaj Auto, Biocon; sell Canara Bank, Chennai Petro: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com is of the view that one can buy Bajaj Auto and Biocon and can sell Canara Bank and Chennai Petro.

  • Biologics biz a large value unlocking opportunity; see revival from Q4: Biocon Jan 25, 2018 12:57 PM IST

    Biologics biz a large value unlocking opportunity; see revival from Q4: Biocon

    We are going to expand our biosimilars pipeline both with Mylan and Sandoz and beyond on our own, said Kiran Mazumdar Shaw, CMD, Biocon.

  • Focus on growth, investments; capacity in Biologics a growth driver: Syngene Intl Jan 24, 2018 02:19 PM IST

    Focus on growth, investments; capacity in Biologics a growth driver: Syngene Intl

    EBITDA Margins around 31-33% with focus on growth and investments are good, said Jonathan Hunt, CEO of Syngene International.

  • Buy Yes Bank, Indiabulls Housing, ICICI Prudential, Biocon: Ashwani Gujral Jan 20, 2018 02:24 PM IST

    Buy Yes Bank, Indiabulls Housing, ICICI Prudential, Biocon: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Yes Bank, Indiabulls Housing, ICICI Prudential and Biocon.

  • Partnership with Sandoz is for the future wave of biosimilars: Biocon Jan 19, 2018 12:28 PM IST

    Partnership with Sandoz is for the future wave of biosimilars: Biocon

    The company is trying to combine forces with companies who have been successful in biosimilars, said Kiran Mazumdar Shaw, CMD, Biocon.

  • Buy Glenmark Pharma, Jain Irrigation Systems; sell Biocon: Ashwani Gujral Jan 10, 2018 11:19 AM IST

    Buy Glenmark Pharma, Jain Irrigation Systems; sell Biocon: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one can buy Glenmark Pharma and Jain Irrigation Systems and can sell Biocon.

Sections